Search

Your search keyword '"Deedwania PC"' showing total 30 results

Search Constraints

Start Over You searched for: Author "Deedwania PC" Remove constraint Author: "Deedwania PC" Topic cardiovascular diseases Remove constraint Topic: cardiovascular diseases
30 results on '"Deedwania PC"'

Search Results

1. GLP-1 receptor agonists and cardiovascular outcomes in patients with type 2 diabetes: Clinical evidence and best practice.

2. Therapeutic Inertia in Cardiovascular Disease Prevention: Time to Move the Bar.

3. 25-Year trends in hypertension prevalence, awareness, treatment, and control in an Indian urban population: Jaipur Heart Watch.

4. Low Prevalence of AHA-Defined Ideal Cardiovascular Health Factors: A Study of Urban Indian Men and Women.

5. Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes.

6. Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study.

7. High prevalence of metabolic syndrome among urban subjects in India: a multisite study.

8. Statins in chronic kidney disease: cardiovascular risk and kidney function.

9. Twenty-year trends in cardiovascular risk factors in India and influence of educational status.

10. Association of educational, occupational and socioeconomic status with cardiovascular risk factors in Asian Indians: a cross-sectional study.

11. The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus.

12. Benefits of statin therapy and compliance in high risk cardiovascular patients.

13. Risk of diabetes and cardiovascular disease: best to return back to the basics: comment on "Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus".

14. Angiotensin receptor blockers: novel role in high-risk patients.

15. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?

16. Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease.

17. Obesity is major determinant of coronary risk factors in India: Jaipur Heart Watch studies.

18. Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).

19. Angiotensin receptor blockers: Cardiovascular protection in the metabolic syndrome.

20. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.

21. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications.

22. Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes.

26. Endothelin, the bad actor in the play: a marker or mediator of cardiovascular disease.

27. The cardiovascular dysmetabolic syndrome.

28. Mechanisms precipitating acute cardiac events: review and recommendations of an NHLBI workshop. National Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute Cardiac Events Participants.

29. Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes

30. Evolocumab and clinical outcomes in patients with cardiovascular disease

Catalog

Books, media, physical & digital resources